Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
University of Milan
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milan (24)
2024
-
The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders
Cellular and Molecular Gastroenterology and Hepatology
2023
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis
Blood, Vol. 141, Núm. 21, pp. 2615-2628
2022
-
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis
Leukemia, Vol. 36, Núm. 8, pp. 2076-2085
-
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Hematological Oncology, Vol. 40, Núm. 5, pp. 987-998
-
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response
Journal of Hematology and Oncology, Vol. 15, Núm. 1
2021
-
Bringing onco‐innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine
Cancers, Vol. 13, Núm. 3, pp. 1-12
-
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
Blood, Vol. 138, Núm. 18, pp. 1721-1726
-
Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine
Cardiovascular research, Vol. 117, Núm. 6, pp. 1428-1433
-
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
Molecular Metabolism, Vol. 53
-
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
Transplantation and Cellular Therapy, Vol. 27, Núm. 10, pp. 807-816
2020
2019
-
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
Liver International, Vol. 39, Núm. S1, pp. 79-97
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
2017
-
Global position paper on cardiovascular regenerative medicine
European Heart Journal
-
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Cancer Cell, Vol. 32, Núm. 1, pp. 88-100.e6
2015
-
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
BMC Genetics, Vol. 16, Núm. 1
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508